Latest News and Press Releases

MIAMI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Veru Inc. (Nasdaq:VERU) (formerly, Nasdaq:FHCO) (”Veru” or the “company”), formerly known as Veru Healthcare/The Female Health Company, a biopharmaceutical...

MIAMI, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (Nasdaq:FHCO) (”Veru” or the “company”), a biopharmaceutical company focused on urology and oncology, today announced that following a...

MIAMI, July 31, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a biopharmaceutical company focused on urology and oncology, today announced that on August 8, 2017, the company will report...

MIAMI, July 20, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a biopharmaceutical company focused on urology and oncology, today announced that the company has initiated the subject...

MIAMI, June 02, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a pharmaceuticals company focused on developing pharmaceuticals for men’s and women’s health and oncology, today announced...

MIAMI, May 24, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a pharmaceuticals company focused on developing pharmaceuticals for men’s and women’s health and oncology, today announced that...

Analysis of men treated with PREBOOST® (topical 4% benzocaine wipes) showed statistically greater improvement in control of ejaculation, satisfaction with sexual intercourse, more pleasure and reduced...

MIAMI, May 09, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO) (the Company) today reported its financial results for the second fiscal quarter ended March 31, 2017.“We are excited about the...

MIAMI, May 02, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that interim and final results from a clinical study of its proprietary product,...

MIAMI, May 02, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that it will report financial results for its fiscal 2017 second quarter on Tuesday,...